SCI Abstract

search
+
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer
Identifying clinical and genomic predictors of response to androgen deprivation therapy (ADT) and androgen receptor pathwa...
From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer
From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer
Metastatic castration-resistant prostate cancer (mCRPC) remains a lethal disease state with limited durable responses to e...
Beyond the Scalpel: how the PROTEUS trial redefines the role of the radical prostatectomy
Taplin M-E, Gleave M, Shore ND, Lopez-Gitlitz A, Kretschmer A, Efstathiou E, et al. Perioperative Apalutamide in High-Risk...
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States
Second-generation androgen receptor pathway inhibitors (ARPIs) have transformed treatment for patients with advanced prost...
Correspondence: persistence, progression, and PSA: what exactly does DEAR-EXT compare? Yanping Zhu, Xiaohui Wang, Yang Zhang, Shuangwu Lv
Competing interests Neal D Shore: Consulting or advisory role: AbbVie, Alkido, A...
Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report
Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report
Hypersensitivity reactions (HSRs) are common complications of taxane chemotherapy and serve as a barrier to key therapies ...
Prostate size and its effect on sexual function following convective water vapor thermal therapy
Prostate size and its effect on sexual function following convective water vapor thermal therapy
Convective water vapor thermal therapy (CWVTT) effectively treats Lower Urinary Tract Symptoms (LUTS) from Benign Prostati...
Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy
Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy
Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is a novel staging mod...
Correction: Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which...
Treatment cycles per unit prostate volume (CPV) for transurethral water vapor therapy (Rezūm) in catheter-dependent patients
For transurethral water vapor therapy (Rezūm), the number of water vapor treatment cycles has classically been determ...
Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study
Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study
Limited data exist on the role of holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the pros...
MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est?
MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est?
Elterman D, Kaplan SA. Reimagining male lower urinary tract symptoms due to benign prostatic hyperplasia treatment: a new ...
Feasibility and safety study of the Flostent™ system (RAPID-I)
Feasibility and safety study of the Flostent™ system (RAPID-I)
This study aimed to evaluate the feasibility and safety of the FloStent™, a novel nitinol prostatic stent, in men wi...
New BPH therapy classification: what really FITs?
The prevalence of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) increases with age. ...
Abiraterone for “STAMPEDE-Like” cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early?
Abiraterone for “STAMPEDE-Like” cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early?
To assess long-term survival in a “STAMPEDE-like” cohort of high-risk locally advanced prostate cancer, staged...
Toward a holistic understanding of Metformin’s Role in oncology: responding to methodological limitations and enhancing translational relevance
TO THE EDITOR:We read with great interest the recent article entitled “ Effect of metformin on incidence, recurrence, and ...
Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study
The article Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthca...
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
Previously, we found low-carbohydrate diets slowed prostate cancer (PC) growth and increased survival vs. a Western diet i...
High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?
Managing biochemical recurrence (BCR) of localized prostate cancers (PCa) that have failed all option...
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Homologous recombination repair mutation (HRRm) status may guide risk-stratification and treatment decisions, including po...
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Identification of emerging molecular biomarkers on circulating tumor cells (CTCs) represents an attractive feature of liqu...
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
While the cardiovascular risks of androgen receptor pathway inhibitors have been studied, they were seldom compared direct...
Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression
Prostate enlargement is a very common pathologic condition [1]: male aging process is associated with...
Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark
Elmansy H, Abbas L, Fathy M, Hodhod A, Shabana W, Alkandari A, et al. Top-down holmium laser enucleation of the prostate (...
The relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy
Rodrigues Pessoa R, Nabavizadeh R, Shah P, Frank I, Tollefson M, Sharma V et al. Relative Impact of Lymph-node Metastasis ...
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) has become an increa...
Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial
Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial
Prostate cancer (PCa) diagnosis relies on biopsies, with transrectal ultrasound (TRUS) biopsies being common. Fusion biops...
High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate
High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate
Both Ductal Adenocarcinoma (DAC) and Intraductal Carcinoma (IDC) of the prostate are generally associated with aggressive ...
Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review
Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review
There is a growing interest about the role of radical prostatectomy (RP) in local cancer control in oligometastatic prosta...
Shifting the paradigm in high-risk prostate cancer: how good is TNM alone?
McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, et al. Post prostatectomy outcomes of patients with high-risk p...
Load More
format_indent_increase